ArticleCancer immunology, immunotherapy : CII2013

Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer.

Stephanie K Bunt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.